Nutraceuticals
Novasep Process Solutions becomes Applexion

Novasep Process Solutions has finalized its carve out from Axplora Group and becomes Applexion, an innovation driven world leader, fully dedicated to provide customers from the agro‐food industry with unique liquid separation and purification solutions.

 

Bridgepoint, the majority shareholder of Applexion, has renewed its support and commitment to the business, recognizing its world leading position in purification technologies for agro‐food industries as well as its strong growth prospects.

Damien Brichant, President of Applexion, said: “Bridgepoint is now enabling us to finalize our transformation into an equipment and services‐oriented company, focusing on decarbonization challenges from our customers. Applexion unveils its new identity, a reminder of our technological and entrepreneurial origins, and confirms the launch of our new offering and innovative digital services that will benefit our customers, throughout the lifecycle of their equipment.”

About Novasep Process Solutions / Applexion

Applexion is an historic & global supplier of purification technologies such as chromatography, ion exchange and ceramic membrane filtration. For the last 15 years, it has designed, built, and commissioned more than 600 units all over the world. The company is internationally recognized for its first‐class services and consumables reliable supply, covering every step of the value chain in the life cycle of each production equipment. With headquarters based at Saint‐Maurice de Beynost (near Lyon, France) and a strong international presence (China & US), Applexion employs 150 people.

About Axplora

Axplora is a premier API manufacturing partner to the world’s leading patient‐centric pharmaceutical and biotechnology companies, delivering top quality active ingredients on time and at scale, to the highest industry standards. Axplora is dedicated to helping pharmaceutical companies make critical medicines better, faster, safely, reliably, and sustainably benefitting patients worldwide. Based at Raubling (near Munich, Germany), Axplora employs 2,400 people in the world.

About Bridgepoint

Bridgepoint Group plc is the world’s leading quoted private assets growth investor focused on the middle‐market with over €37 billion AUM and a local presence in the US, Europe and China, specializing in private equity and private credit. Bridgepoint invests internationally in six principal sectors – business services, consumer, financial services, healthcare, advanced industrials and technology.